ÂÜÀòÂÒÂ×

The Research and Development Team at Lucy Therapeutics is dedicated to advancing the company's innovative drug discovery efforts by conducting rigorous experimental studies to validate targets associated with early disease pathogenesis. This team leverages their expertise in mitochondrial function to explore and develop novel therapeutic strategies for CNS diseases such as Rett Syndrome and Parkinson’s, ensuring a focus on disease modification rather than symptom management. Through collaboration and cross-functional research, they aim to establish proof of concept and optimize dosing regimens to enhance neuroprotection and potential clinical outcomes.